Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$24.87 - $38.56 $151,707 - $235,216
-6,100 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$25.43 - $36.67 $155,123 - $223,687
6,100 New
6,100 $220,000
Q3 2019

Nov 13, 2019

SELL
$23.0 - $27.97 $609,500 - $741,205
-26,500 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$22.81 - $28.48 $604,465 - $754,720
26,500 New
26,500 $638,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Barings LLC Portfolio

Follow Barings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barings LLC with notifications on news.